La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Ocean Biomedical a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Ocean Biomedical..

Ocean Biomedical (OTC:OCEA) Azioni, Catena delle Opzioni

Ocean Biomedical

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

OCEAN BIOMEDICAL INC by Ocean Biomediacal, Inc.

Ocean Biomedical Inc

Ocean Protocol - United States dollar

Ocean Biomedical Inc Warrants (14/02/2028)

Ocean Power Technologies, Inc. Common Stock

Ocean Power Technologies Inc

Oceaneering International, Inc. Common Stock

Oceaneering International Inc

OceanFirst Financial Corp. - Common Stock

OceanFirst Financial Corp

OceanPal Inc

OceanaGold Corp

Ocean Park High Income ETF

OCEANIC IRON ORE CORP NEW by Oceanic Iron Ore Corp.

Oceanic Iron Ore Corp

Ocean Park International ETF

OCEAN SPRAY 4 PR by Ocean Spray Cranberries, Inc.

Ocean Spray Cranberries Inc

OCEAN THERMAL ENERGY CORP by Ocean Thermal Energy Corp.

Ocean Thermal Energy Corp

OceanTech Acquisitions I Corp

OceanTech Acquisitions I Corp Units (1 Ord Class A & 1 War)

OceanTech Acquisitions I Corp Warrants (12/05/2026)

OceanTech Acquisitions I Corp Class A

Oceana Group Ltd

OCEANAGOLD (PHILIPPINES) by OceanaGold (Philippines), Inc.

OceanaGold Philippines Inc

OCEANIA HEALTHCARE LTD by Oceania Healthcare Ltd.

Oceania Healthcare Ltd

OCEANIC WIND ENERGY INC. by Oceanic Wind Energy Inc.

Oceanic Wind Energy Inc

Press Releases

Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors.

Comments

Ocean Biomedical

Ocean Biomedical (OCEA) Opzioni

Ocean Biomedical (OTC:OCEA) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO